In another study, BRAF mutations, while rarer, appear more frequently in malignant carcinomas compared to their benign and borderline counterparts (51).The intricate molecular landscape, detailing the mutational profiles of MOC, mucinous borderline tumors, HGSC, and colorectal cancer, is systematically presented in Table 2. Here, BRAF is linked to carcinoma.